Treatment Patterns and Health Care Costs in Commercially Insured Patients with Follicular Lymphoma
**Background:** Few studies have estimated the real-world economic burden such as all-cause and follicular lymphoma-related costs and health care resource utilization (HCRU) in patients with follicular lymphoma (FL). **Objectives:** This study evaluated outcomes in patients who were newly initiate...
Saved in:
Main Authors: | Nathan H. Fowler, Guifang Chen, Stephen Lim, Stephanie Manson, Qiufei Ma, Frank Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2020-09-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/jheor.2020.16784 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis
by: Scott F. Huntington, et al.
Published: (2022-10-01) -
Deep immunophenotypic dissection and clinical impact of T cells in the follicular lymphoma microenvironment
by: Sary El Daker, et al.
Published: (2025-02-01) -
Plasmablastic transformation of a double hit follicular lymphoma: An emerging entity
by: Shanaz Khodaiji, et al.
Published: (2024-04-01) -
Impact of positive CD4 cells on event‐free survival in follicular lymphoma patients
by: Cong Li, et al.
Published: (2024-09-01) -
The age-adjusted international prognostic index 2 (A-FLIPI2) for elderly patients with follicular lymphoma
by: Jiesong Wang, et al.
Published: (2025-02-01)